A growing trend among women in Hong Kong involving anti-aging injections derived from human tissue has triggered a formal crackdown by local health authorities. The product, commonly referred to as the “cadaver skin jab,” specifically involves a substance known as Elravie Re2O. Despite its increasing popularity in beauty circles, the product has not been registered for medical or cosmetic use within the city, leading officials to caution the public against its application.

The procedure is marketed as an anti-aging treatment, though its efficacy and safety profile remain subjects of concern for medical professionals. Because the substance is derived from human cadaveric tissue, it carries inherent biological risks, including the potential for infection or immune reactions if not processed and administered under strict medical supervision. Health authorities emphasize that using unregistered medical products bypasses the safety standards required to ensure that such treatments are free from contaminants or pathogens.

While the trend has gained traction due to aggressive marketing and social media influence, the lack of regulatory approval means there is no oversight regarding the source of the tissue or the manufacturing process. Officials are urging consumers to prioritize safety over cosmetic trends and are actively monitoring the market to prevent the distribution of these unauthorized injections. The situation highlights the ongoing challenge regulators face in keeping pace with underground beauty trends that leverage medical terminology to attract consumers seeking rapid anti-aging results.